NantKwest: $222.5M Raised In IPO

Culver City-based NantKwest, the immunotherapy developer aiming to treat cancer with its technology, said Friday that it raised a total of $22.5M in its IPO, where it sold 9,531,200 shares of its stock at $25.00 per share. The company's stock is now hovering around $30.00 per share. The company's market cap is now around $2.14 billion. NantKest--formerly known as Conkwest--was mostly owned by biotech billionaire Patrick Soon-Shiong before the IPO. The company is now trading as NK on the Nasdaq.